Vascular endothelial growth factor (VEGF) inhibitors currently used to treat eye diseases have
included monoclonal antibodies, antibody fragments, and an aptamer. A different method …

Purpose: To find out whether intravitreally administered bevacizumab and ranibizumab affect
the contralateral, untreated, eyes of patients with bilateral diabetic macular edema (DME). …

Objective To evaluate the diagnostic ability of macular ganglion cell complex (GCC) and
peripapillary nerve fibre layer (NFL) measurements to detect ganglion cell loss (GCL) in …

Purpose: To evaluate the effect of pupil dilation on the biometric parameters of the Lenstar
LS 900 (Haag Streit AG, Koeniz, Switzerland). Methods: In this cross-sectional study of 33 …

Purpose: To compare the accuracy of optical low-coherence reflectometry (Lenstar LS 900;
Haag Streit, Köniz, Switzerland) and conventional ultrasound pachymetry (UP)(US 4000; …

Objective: To investigate the effect and safety of intravitreal injection (IVI) of bevacizumab
and ranibizumab on corneal endothelial cell count and morphology in patients with diabetic …

Purpose: Cisplatin and Paclitaxel are two chemotherapeutic agents known to produce
neurotoxicity when used for cumulative dose regimens. In this study we aim to assess their toxicity …

Purpose: Genetic factors are known to influence the response to anti-vascular endothelial
growth factor (VEGF) treatment in exudative age-related macular degeneration (AMD). The …

A 36-year-old woman with a 3-month history of progressive visual loss had papilledema,
dilatation of the optic nerve sheaths and normal cerebrospinal fluid pressures. She was …

Purpose: To compare the results of central corneal thickness (CCT) measurements obtained
using optical low-coherence reflectometry (OLCR), Fourier domain optical coherence …